HIGHLIGHTS
- What: In this paper, the authors review the strategies proposed for improving the coordination of the CAR T-cell therapy supply chain. The paper discusses the impact of the interfaces between stakeholders on the ability to prioritize supply chain goals, implement proposed strategies, and overcome barriers to treatment access. In this context, the authors aim to present a review that highlights the importance of considering the degree of interaction between all stakeholders, including secondary and support stakeholders, to gain a comprehensive understanding of the barriers that limit access to CAR T-cell therapy. Stakeholder coordination ensures that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.